Tag Cloud Results

Results found matching tag first

From the News
Straumann reports stable net revenues of CHF 362 million in first half of 2012
Lonza Delivered Solid Business Performance in the First Half of 2012
Novartis receives EU approval for Votubia, the first medication to treat children and adults with SEGA ...
Bruker Introduces PRIME, the first Integrated Multidimensional Solution for Unraveling the Proteome
Roche’s Tarceva receives European approval for first-line use in a genetically distinct type of lung ...
Santhera Announces Interim Financial Results for the First Half Year of 2011 and Restructuring Plans ...
R&D spend by 15 top MNCs up by 8.2% in first half of 2011 with no blockbusters in sight
Dow AgroSciences, M.S. Technologies Submit for Approval First Ever Three-Gene Herbicide-Tolerant Soybean
First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical ...
Anacor Announces First Development Candidate in Animal Health under Research Collaboration with Eli Lilly ...
New potato-enhancing product Emesto registered in first market
Abbott Labs First in Foreign Trade Zone
Celebrity Chef Sam Talbot Joins “Life First” Diabetes Awareness Campaign
Roche’s Tarceva gains positive CHMP opinion for first-line use in genetically distinct type of lung ...
Agilent Technologies Appoints Molecular Genomics as Its First Certified Service Provider for Microarrays ...
Cardinal Health Launches First-of-its-Kind Molecular Imaging "Collaboration Center"
Life Technologies Introduces First and Only USDA-Approved Real-Time PCR Test to Detect Swine Influenza ...
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada*) in Multiple ...
Basilea initiates first-in-human study with its novel anti-cancer drug BAL101553
Dow AgroSciences Announces the First Saturated Fat Free Oil Product
Evolva to receive first milestone payment from Roche
Dow AgroSciences is First Company Accredited by USDA Seed Conditioning Program
Transgene held its first R&D Day
Agilent Technologies Publishes Industry's First Compendium to Test for Synthetic Marijuana Compounds
Basilea reports positive results from first clinical phase I study with its novel antibiotic BAL30072
First international flight by Solar Impulse plane
Sanofi Pasteur Launches Pentaxim, First 5-in-1 Combination Vaccine in China
Novartis drug Votubia approved as first medication in Switzerland for SEGA
EPA Registers First Dow AgroSciences 2,4-D Choline Product Submission
Novartis gains FDA approval for Afinitor as first new treatment in nearly three decades for patients ...
QIAGEN & Merck Launch Africa’s First Comprehensive Cervical Cancer Prevention Program Incorporating ...
Roche gains positive CHMP opinion for the combination of Avastin with Xeloda as a first-line treatment ...
BYDUREON Would Be First Once-Weekly Treatment for Adults with Type 2 Diabetes
Agilent Appoints BGI First Certified Service Provider in China for Target Enrichment System for Next-Gen ...
Novartis first-in-class antiviral DEB025 achieved sustained viral response in 76% of patients with chronic ...
Partnership marks agilent's first collaboration in lipidomics research and development worldwide
Pall GeneDisc system first AOAC validated test for non-O157 STEC in food safety
First monomeric HALS light stabilizer registered for food contact applications in plastics
First Five-Gene Trait Stack Technology from Dow AgroSciences Approved in Brazil
LGC Standards offers world’s first certified reference nanomaterial
Mylan Confirms First-to-File Patent Challenge by Novartis Relating to Vivelle-Dot
Dow AgroSciences Receives First International Patent Publication for Lead Commercial Event in Herbicide ...
Auris Medical starting enrolment in first US clinical trial with AM-101
Roche Teams with Womack Army Medical Center to Become First IVD Manufacturer approved for Remote Network ...
Genedata Biologics – First Commercial Biologics Data Management and Analysis Platform Announced at ...
Halozyme announces roche doses first patient in phase 3 clinical trial with subcutaneous MabThera (rituximab)
Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First ...
Agilent Technologies Reports First Quarter 2011 Results
Lilly collaboration with outside researchers yields first deal
Huntsman announces first quarter 2011 common dividend and details of 2011 Annual Meeting of Stockholders